Literature DB >> 1346703

Pulmonary hypertension and dexfenfluramine.

P G Atanassoff, B M Weiss, E R Schmid, M Tornic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1346703

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

Review 1.  Respiratory toxicities from stimulant use.

Authors:  T E Albertson; W F Walby
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

2.  Advance modern medicine with clinical case reports.

Authors:  Yì-Xiáng J Wáng
Journal:  Quant Imaging Med Surg       Date:  2014-12

Review 3.  Safety of drug therapies used for weight loss and treatment of obesity.

Authors:  Lisa L Ioannides-Demos; Joseph Proietto; Andrew M Tonkin; John J McNeil
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

4.  Pulmonary hypertension and dexfenfluramine.

Authors:  P Cacoub; R Dorent; P Nataf; J P Houppe; J C Piette; P Godeau; I Gandjbakhch
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 5.  Dietary pulmonary hypertension.

Authors:  J M Kay
Journal:  Thorax       Date:  1994       Impact factor: 9.139

6.  Exploration of the pulmonary circulation. Festschrift to Professor Donald Heath.

Authors: 
Journal:  Thorax       Date:  1994       Impact factor: 9.139

7.  Serotonylated fibronectin is elevated in pulmonary hypertension.

Authors:  Lin Wei; Rod R Warburton; Ioana R Preston; Kari E Roberts; Suzy A A Comhair; Serpil C Erzurum; Nicholas S Hill; Barry L Fanburg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-04-20       Impact factor: 5.464

Review 8.  Dexfenfluramine. A review of its pharmacological properties and therapeutic potential in obesity.

Authors:  D McTavish; R C Heel
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

9.  Appetite suppressants and primary pulmonary hypertension in the United Kingdom.

Authors:  S H Thomas; A Y Butt; P A Corris; J J Egan; T W Higenbottam; B P Madden; P C Waller
Journal:  Br Heart J       Date:  1995-12

Review 10.  Role of serotoninergic pathways in drug-induced valvular heart disease and diagnostic features by echocardiography.

Authors:  Sakima A Smith; Alan D Waggoner; Lisa de las Fuentes; Victor G Davila-Roman
Journal:  J Am Soc Echocardiogr       Date:  2009-06-23       Impact factor: 5.251
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.